FRANKLIN RESOURCES INC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,816,714
+1.3%
73,736
-4.4%
0.00%0.0%
Q2 2023$2,780,888
-86.4%
77,097
-85.6%
0.00%
-90.0%
Q1 2023$20,471,329
-66.2%
536,039
-49.6%
0.01%
-67.7%
Q4 2022$60,567,944
+43.7%
1,064,463
-0.2%
0.03%
+34.8%
Q3 2022$42,155,000
+39.2%
1,066,132
+54.9%
0.02%
+53.3%
Q2 2022$30,282,000
+1719.8%
688,216
+1548.8%
0.02%
+1400.0%
Q1 2022$1,664,000
-5.8%
41,741
-5.0%
0.00%0.0%
Q4 2021$1,766,000
+6.8%
43,932
+8.1%
0.00%0.0%
Q3 2021$1,653,000
+410.2%
40,645
+469.7%
0.00%
Q2 2021$324,000
+17.0%
7,135
+7.5%
0.00%
Q1 2021$277,000
+5.3%
6,640
+7.7%
0.00%
Q4 2020$263,000
-97.4%
6,168
-99.4%
0.00%
-100.0%
Q4 2016$10,214,000
-62.1%
1,033,808
-53.6%
0.01%
-64.3%
Q3 2016$26,927,000
+40.7%
2,229,069
+0.5%
0.01%
+40.0%
Q2 2016$19,132,000
-9.0%
2,216,929
-0.1%
0.01%
-9.1%
Q1 2016$21,022,000
-33.2%
2,219,933
+22.2%
0.01%
-31.2%
Q4 2015$31,476,000
+29.7%
1,816,288
+0.5%
0.02%
+33.3%
Q3 2015$24,265,000
-48.1%
1,806,737
-12.7%
0.01%
-42.9%
Q2 2015$46,728,000
+65.9%
2,069,425
+4.9%
0.02%
+61.5%
Q1 2015$28,164,000
-33.2%
1,972,246
-40.6%
0.01%
-35.0%
Q1 2014$42,147,000
+2.6%
3,318,700
+21.1%
0.02%0.0%
Q4 2013$41,067,000
+33.1%
2,739,600
-2.0%
0.02%
+25.0%
Q3 2013$30,863,000
+88.6%
2,795,600
+35.7%
0.02%
+77.8%
Q2 2013$16,363,0002,060,8000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Bellevue Group AG 318,000$3,841,0000.69%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders